Key result
The renin-angiotensin-aldosterone system plays a major role in regulating cardiac fibrosis, and ACE inhibitors are able to delay its development.
Cardiac fibrosis is a major problem in cardiology, and the renin-angiotensin-aldosterone system plays a key role in its regulation.
ecause of the increase in life expectancy and a high survival rate after myocardial infarction, cardiac fibrosis is becoming one of the most important problems in cardiology.It is characterized by excessive accumulation of fibrillar collagen in the extracellular space, either because of a loss of cardiomyocytes (replacement fibrosis) and/or as an interstitial response to various chronic cardiovascular diseases such as hypertension, myocarditis, and congestive heart failure (reactive fibrosis). 1In humans, cardiac fibrosis is universal in the aging heart.Activated fibroblasts play a pivotal role in the formation and maintenance of fibrous tissue by the production of various extracellularmatrix proteins, including collagen and fibronectin.It is now recognized that even in areas with long-standing fibrosis, such as postinfarction scars, fibroblasts remain metabolically active. 2 Their activity is regulated by various autocrine and paracrine factors, such as angiotensin II, aldosterone, endothelins, cytokines, and growth factors. 3The renin-angiotensin-aldosterone system is considered to be of major importance for the regulation of cardiac fibrosis.Increased tissue levels of angiotensin II have shown to promote, and ACE inhibitors are able to delay the development of, cardiac fibrosis. 4,
No takes yet. Share an insight, caveat, or question.
Allessie et al. (2005) conducted a review in Cardiac fibrosis. Gene therapy was evaluated. The renin-angiotensin-aldosterone system plays a major role in regulating cardiac fibrosis, and ACE inhibitors are able to delay its development.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: